Atyr Pharma Inc
ATYR
Revenue
0.00
▼-235.00k▼-100.00%
3 Months ChangeAssets
105.94M
▼-7.31M▼-6.46%
3 Months ChangeLiabilities
24.33M
▼-4.45M▼-15.47%
3 Months ChangeFree Cash Flow
-22.40M
▼-20.56M▼-1119.88%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0000950170-24-096185
2024-08-13
Form 8-K
ID: 0000950170-24-096139
2024-07-22
Form 8-K
ID: 0000950170-24-085058
2024-05-29
Form 8-K
ID: 0000950170-24-065899
2024-05-02
Form 10-Q
ID: 0000950170-24-052092
2024-05-02
Form 8-K
ID: 0000950170-24-052058
2024-03-14
Form 8-K
ID: 0000950170-24-031441
2023-11-09
Form 10-Q
ID: 0000950170-23-062058
2023-11-09
Form 8-K
ID: 0000950170-23-062020
2023-09-26
Form 8-K
ID: 0000950170-23-049802